Condition: Obstructive Sleep Apnea · Sponsor: University of Pennsylvania
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
This description comes directly from the study's public registry record.
Colleen M Walsh, MS · 215-614-0047 · walshco@pennmedicine.upenn.edu
Kristie C Nguyen · 215-615-4112 · kristie.nguyen@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600 | Columbus, Ohio, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Iceland | Reykjavik, Iceland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06189755